Systems and methods for embolization procedures for treatment of defects in the vasculature

Methods and systems including an N-butyl cyanoacrylate ("n-BCA") liquid embolic agent and achieving, by the n-BCA liquid embolization agent, a reduction in total cost of preoperative embolization procedures for a plurality of patients versus an ethylene vinyl alcohol copolymer ("EVOH&...

Full description

Saved in:
Bibliographic Details
Main Authors Satti, Sudhakar, Fan, Xiaozhou, Kottenmeier, Emilie, Ikeme, Shelly, Khanna, Rahul
Format Patent
LanguageEnglish
Published 07.03.2023
Subjects
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY
DIAGNOSIS
HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
MEDICAL OR VETERINARY SCIENCE
PHYSICS
SURGERY
Online AccessGet full text

Cover

More Information
Summary:Methods and systems including an N-butyl cyanoacrylate ("n-BCA") liquid embolic agent and achieving, by the n-BCA liquid embolization agent, a reduction in total cost of preoperative embolization procedures for a plurality of patients versus an ethylene vinyl alcohol copolymer ("EVOH") liquid embolic agent. Methods and systems for reducing supply costs of preoperative embolization by at least approximately 18% are described.
Bibliography:Application Number: US202117471834